Loss of FHIT Expression in Transitional Cell Carcinoma of the Urinary Bladder
- 1 February 2000
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (2) , 419-424
- https://doi.org/10.1016/s0002-9440(10)64745-1
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA56036)
This publication has 37 references indexed in Scilit:
- Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.2000
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Direct Cloning of DNA Sequences from the Common Fragile Site Region at Chromosome Band 3p14.2Genomics, 1996
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract CancersCell, 1996
- FRA3B Extends Over a Broad Region and Contains a Spontaneous HPV16 Integration Site: Direct Evidence for the Coincidence of Viral Integration Sites and Fragile SitesHuman Molecular Genetics, 1996
- Fhit, a Putative Tumor Suppressor in Humans, Is a Dinucleoside 5‘,5‘ ‘‘-P1,P3-Triphosphate HydrolaseBiochemistry, 1996
- Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progressionInternational Journal of Cancer, 1993
- Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumoursNature, 1984
- Hereditary Renal-Cell Carcinoma Associated with a Chromosomal TranslocationNew England Journal of Medicine, 1979